GS
Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1226
AT&T
T
$210B
|
BF
Brett Feldman
| $29.36 | $20 |
32%
downside
| Buy |
27 Jul ‘23
2 years ago |
|
1227
Zurn Elkay Water Solutions
ZWS
$7.85B
|
JR
Joe Ritchie
| $46.84 | $31 |
34%
downside
| Buy |
26 Jul ‘23
2 years ago |
|
1228
Verizon
VZ
$185B
|
BF
Brett Feldman
| $43.91 | $36 |
18%
downside
| Neutral |
26 Jul ‘23
2 years ago |
|
1229
Kiniksa Pharmaceuticals
KNSA
$2.69B
|
PC
Paul Choi
| $36.33 | $32 |
12%
downside
| Buy |
26 Jul ‘23
2 years ago |
|
1230
ManpowerGroup
MAN
$1.79B
|
GT
George Tong
| $38.70 | $79 |
104%
upside
| Sell |
24 Jul ‘23
2 years ago |
|
1231
Verisk Analytics
VRSK
$37.1B
|
AB
Andre Benjamin
| $265.65 | $240 |
10%
downside
| Neutral |
21 Jul ‘23
2 years ago |
|
|
TE
1232
T1 Energy Inc.
TE
$301M
|
PK
Philipp Konig
| $1.93 | $10 |
418%
upside
| Neutral |
18 Jul ‘23
2 years ago |
|
1233
Ranpak Holdings
PACK
$413M
|
AS
Adam Samuelson
| $4.89 | $5 |
2%
upside
| Neutral |
18 Jul ‘23
2 years ago |
|
1234
LSB Industries
LXU
$578M
|
AS
Adam Samuelson
| $8.04 | $10.50 |
31%
upside
| Neutral |
18 Jul ‘23
2 years ago |
|
1235
BridgeBio Pharma
BBIO
$10.1B
|
PC
Paul Choi
| $52.82 | $50 |
5%
downside
| Buy |
18 Jul ‘23
2 years ago |
|
1236
Enhabit
EHAB
$407M
|
JP
Jamie Perse
| $8.02 | $13 |
62%
upside
| Neutral |
17 Jul ‘23
2 years ago |
|
1237
Alkami Technology
ALKT
$2.64B
|
CM
Christopher Merwin
| $25.40 | $21 |
17%
downside
| Buy |
12 Jul ‘23
2 years ago |
|
1238
Graco
GGG
$14.2B
|
JR
Joe Ritchie
| $85.94 | $87 |
1%
upside
| Neutral |
10 Jul ‘23
2 years ago |
|
1239
Alcoa
AA
$8.26B
|
EC
Emily Chieng
| $31.92 | $46 |
44%
upside
| Buy |
10 Jul ‘23
2 years ago |
|
1240
Pacific Biosciences
PACB
$375M
| $1.25 | $17 |
1,260%
upside
| Buy |
30 Jun ‘23
2 years ago |
|
|
1241
Foghorn Therapeutics
FHTX
$301M
|
PC
Paul Choi
| $5.32 | $19 |
257%
upside
| Buy |
29 Jun ‘23
2 years ago |
|
1242
FibroGen
FGEN
$49.3M
|
PC
Paul Choi
| $12.19 | $50 |
310%
upside
| Sell |
27 Jun ‘23
2 years ago |
|
1243
Itaú Unibanco
ITUB
$77.1B
|
TL
Tito Labarta
| $7.17 | $6.55 |
9%
downside
| Buy |
22 Jun ‘23
2 years ago |
|
1244
Immunocore
IMCR
$1.83B
|
RS
Rajan Sharma
| $36.23 | $79 |
118%
upside
| Overweight |
20 Jun ‘23
2 years ago |
|
1245
Diageo
DEO
$57.9B
|
ON
Olivier Nicolai
| $104.19 | $186.48 |
79%
upside
| Neutral |
15 Jun ‘23
2 years ago |
|
1246
EOG Resources
EOG
$65.4B
|
NM
Neil Mehta
| $119.76 | $130 |
9%
upside
| Neutral |
13 Jun ‘23
2 years ago |
|
1247
Xylem
XYL
$34.5B
|
BL
Brian Lee
| $141.88 | $133 |
6%
downside
| Buy |
8 Jun ‘23
2 years ago |
|
1248
Public Service Enterprise Group
PEG
$40.8B
|
ML
Michael Lapides
| $81.69 | $64 |
22%
downside
| Neutral |
8 Jun ‘23
2 years ago |
|
1249
Xcel Energy
XEL
$43B
|
CD
Carly Davenport
| $72.78 | $75 |
3%
upside
| Buy |
8 Jun ‘23
2 years ago |
|
1250
Consolidated Edison
ED
$35B
|
ML
Michael Lapides
| $97.10 | $88 |
9%
downside
| Sell |
8 Jun ‘23
2 years ago |
|